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1. Introduction 
The aryl hydrocarbon receptor (AhR), a ligand-dependent transcription factor, mediates a 
variety of biological processes [[1]]. AhR is a classic receptor for environmental 
toxicants/carcinogens such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 3-
methylcholanthrene (3MC). Upon binding to these ligands, AhR could adversely affect 
embryonic and fetal growth as well as male and female reproduction [[1],[2]]. For instance, 
prenatal exposure to TCDD may cause fetotoxicity, delayed puberty, decreased sperm 
count, and reduced fertility [[2]]. Interestingly, AhR knockout in mice can also lead to 
similar adverse phenotypes in the reproductive system (e.g., impaired implantation and 
pregnancy) [[3]-[6]]. Thus, these data clearly indicate the physiological roles of AhR in 
implantation and pregnancy. 
Preeclampsia is a life threatening complication of pregnancy, accounting for almost 10-15% 
of pregnancy-associated deaths and one of the major causes of iatrogenic prematurity 
among newborns [[7]]. The pathogenesis of preeclampsia is thought to act at three levels, 
defective placentation, placental ischemia, and endothelial cell dysfunction.  
Protein expression of AhR has been identified in the placentas of many mammalian species 
including mouse and rabbit [[8],[9]]. Human placentas also contained high density of 
specific binding sites for TCDD as compared with rat and mouse livers, implying high AhR 
expression in human placentas [[10]]. This was confirmed by the observation that human 
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placentas had highest levels of AhR mRNA among many human organs including lung, 
liver, heart, brain, and kidney [[11]]. Recently, we have also reported that AhR protein is 
highly expressed in term human placentas, although no difference in AhR protein levels 
was detected between normal (N) and severe preeclamptic (sPE) placentas [[12]]. However, 
the information on AhR protein expression in mild preeclamptic (mPE) and first trimester 
placentas was still lacking. Herein, we examined the AhR protein expression in term human 
placentas from women with N and mPE pregnancies as well as in first trimester placentas 
using immunohistochemistry and Western blotting.  
2. Materials and methods 
2.1 Tissue collection 
Term placentas were obtained immediately after cesarean section delivery from women 
with N (n = 14) and mPE (n = 10) pregnancies as described [[12],[13]]. The first trimester 
placentas (n = 12) were obtained from women with induced abortion at gestation time of 6-8 
weeks. Collection of placentas was approved by the Ethics Committee of Shanghai First 
Maternity and Infant Hospital, Tongji University School of Medicine. Written informed 
consent to participate in the study was obtained from each patient. Preeclampsia was 
defined according to the guideline of USA National Institutes of Health publication No. 00-
3029 [[14]]. The mPE was defined as onset of hypertension during late pregnancy with 
systolic and diastolic blood pressure more than 140 / 90 mmHg on at least two occasions 
and urinary protein more than 0.3g / 24h. All of the study subjects didn’t have any 
medication during gestation. They were free of major diseases and substance abuse. 
Smokers were excluded. Patients’ ages were similar between N and mPE pregnancies. There 
was no significant difference in gestation ages and fetal weights between N and mPE 
pregnancies (see table 1). Placental tissues under the chorionic and basal plates were 
dissected (~10 g each), snap-frozen and quickly stored in liquid nitrogen for Western 
blotting. Additional placental tissues from first trimester (n = 5) and term placentas (n = 5), 
and mPE placentas (n = 5) were fixed overnight at 4°C using 4% paraformaldehyde in 10 
mM PBS and embedded them in paraffin for immunohistochemistry. 
 
 
Characteristics 
Normal 
(n = 14) 
Mild PE 
(n = 10) 
P value 
(p ≤ 0.05) 
Patient ages (yr) 24 ± 1.2 25±1.8 NS 
Gestation ages (wk) 39 ± 0.2 38 ± 0.6 NS 
Fetal weights (g) 3414 ± 80.3 2966 ± 130.2 NS 
Data are expressed as means ± SEM, p ≤ 0.05 is considered statistically significant 
Table 1. The characteristics of women from normal and mPE pregnancies.  
2.2 Immunohistochemistry 
Immunolocalization of AhR in placental tissues was visualized by indirect observation via 
the avidin:biotinylated-peroxidase complex method (Vector Laboratories, Burlingame, CA) 
as described [[12],[13]]. Tissue sections (5 μm thick) were deparaffinized and dehydrated, 
followed by incubating the sections in a 10 mM citrate buffer solution (pH 6.0) in a 
microwave for 10 min for antigen retrieval. Then the tissue sections were immersed in 3% 
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H2O2 in methanol for 10 min in order to quench endogenous peroxidase activity. After 
blocking the non-specific binding sites with 1% horse serum albumin, the sections were 
incubated with a rabbit AhR antibody (1:500; BIOMOL International, Plymouth Meeting, 
PA) for 1 h and a biotinylated mouse anti-rabbit antibody (ABC kit; Vector Laboratories) for 
30 min. The specific immunoreactivity was visualized by 3-amino-9-ethylcarbazole (AEC, 
Vector Laboratories). The tissue sections were lightly counter-stained with Harris Modified 
Hematoxylin (Fisher Scientific, Pittsburgh, PA). Additional adjacent tissue sections as 
negative controls were incubated with the same dilution of preimmune rabbit IgG as the 
primary antibody. 
2.3 Western blotting  
Western blotting was carried out as described [[12],[13]]. Placental tissues were pulverized 
in liquid nitrogen using a mortar and pestle, followed by prepared in RIPA lysis buffer (50 
mM HEPES, 0.1 M NaCl, 10 mM EDTA, 4 mM sodium pyrophosphate, 10 mM sodium 
fluoride, 2 mM sodium orthovanadate [pH 7.5]; 1 mM phenyl methyl sulfonyl fluoride 
[PMSF], 1% Triton X-100, 5 µg/ml leupeptin, 5 µg/ml aprotinin), and further lyzsed by 
sonication. After centrifugation, the supernatant was saved and protein concentrations in 
supernatants were determined by BCA kit.  
The protein samples (40 g) were subjected to electrophoresis on 10% SDS-PAGE gels, 
followed by electrically transferring to polyvinylidene difluoride membranes. The 
membranes were incubated with the AhR antibody (1:2000; BIOMOL) and then reprobed 
with a GAPDH (1:5000; KANGCHEN, Shanghai, China) antibody as a loading control. 
Membranes were reacted with ECL reagents (Amersham Biosciences, Piscataway, NJ). Protein 
bands on the membranes were visualized by exposuring them to chemiluminescence films. 
The immunoreactive signals were analyzed by densitometry. The optical density (OD) value 
was measured by the Image-J imaging analysis software (US National Institutes of Health; 
Bethesda, MD). 
 
Fig. 1. Immunolocalization of AhR in human placentas from women with normal and mPE 
pregnancies. The adjacent tissues sections were incubated either with a rabbit AhR antibody 
(4 g/ml) or preimmune rabbit IgG (4 g/ml; in inserts). Reddish color indicates positive 
staining for AhR. Representative images from N (A) and mPE (B) pregnancies are shown. 
Arrows heads, syncytiotrophoblasts; asterisk, lumen of blood vessels. Bar, 100 m. 
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2.4 Statistics procedures  
Data for the AhR protein levels were analyzed using the Student’s t-test (SigmaStat; Jandel 
Co., San Rafael, CA); *p ≤ 0.05 were considered to be statistically significant. 
3. Results 
3.1 AhR protein localization and expression in N and mPE placentas 
Positive reddish staining for AhR was observed primarily in syncytiotrophoblasts in N and 
mPE placentas. There was also moderate staining in endothelial cells from large blood 
vessels (Fig. 1A and 1 B) as described ([12]). The protein levels of AhR in N and mPE 
placentas were further determined by Western blotting (Fig. 2). The AhR band was detected 
at ~95 kDa (Fig. 2A) as previously reported in many species including human [[12],[15]]. 
The AhR protein levels in mPE placentas were approximately 5.6 fold higher (p ≤ 0.05) than 
those in N placentas (Fig. 2B). 
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Fig. 2. Western blot analysis for AhR in human placentas from women with N and mPE 
pregnancies. Human placentas were obtained from N (n = 14) and mPE (n = 10) 
pregnancies. Representative Western blot images are shown for AhR and GAPDH. Data 
normalized to GAPDH are expressed as means  SEM fold of N placentas. *Differs (p ≤ 0.05) 
from the N placentas. 
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3.2 Protein expression of AhR in first trimester placentas 
Similar to term plancentas, AhR was also mainly immunolocalized in syncytiotrophoblasts 
in first trimester placental villi (Fig. 3A). However, in contrast to term placentas, moderate 
positive AhR staining was observed in capillaries within first trimester placental villi (Fig. 
3B), suggesting the possible roles of AhR in mediating placental endothelial functions 
including angiogenesis during human early pregnancy. Western blot analysis indicated that 
overall AhR protein levels in term placentas were ~ 2.2 fold higher (p ≤ 0.05) than those in 
first trimester placentas (Fig. 4).  
 
Fig. 3. Immunolocalization of AhR in human first trimester placentas. Reddish color 
indicates positive staining for AhR. Representative images from first-trimester placentas are 
shown. Arrow heads, syncytiotrophoblasts; arrows, cytotrophoblasts; asterisk, lumens of 
blood vessels. Bar, 100 m. 
4. Disscusion 
In the current study, we have described the expression and localization of AhR protein in 
human term placentas from N and mPE preeclamptic pregnancies as well as in human first 
trimester placentas using immunohistochemistry and Western blot analyses. It is the first, as 
far as we know, to report that higher AhR protein levels were associated with mPE, while 
much higher AhR protein levels were expressed in term placentas as compared to first 
trimester placentas. Another major finding of the current study was that intense AhR 
staining was detected primarily in syncytiotrophoblasts in both first trimester and term 
placentas. Interestingly, moderate AhR expression was observed in capillary endothelial 
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Fig. 4. Western blot analysis for AhR in human first trimester and full term placentas.  First 
trimester (n = 12) placentas were obtained from women with induced abortion at 5 to 8 
weeks of gestation without any complications. Representative Western blots are shown for 
AhR and GAPDH. Data normalized to GAPDH are expressed as means ± SEM fold of first 
trimester placentas. *Differs (p ≤ 0.05) from first trimester placentas. 
cells within villi in the first trimester, but not term placentas (the current study and [12]). 
These findings suggest that AhR might play a critical role in mediating syncytiotrophoblast 
function, particularly in mPE and term placentas. The distinct distribution patterns of AhR 
protein in different placental vasculatures (capillaries vs. large blood vessels) during early 
and late pregnancies also imply that AhR might differentially mediate placental endothelial 
functions. For example, AhR may actively mediate placental angiogenesis at early 
pregnancy and placental vasodilatation during late pregnancy. 
The expression of AhR mRNA and protein has been reported in the placenta of many 
mammalians including mouse and rabbit [[8],[9]]. We have also reported the AhR protein 
expression in the term human placenta from N and sPE pregnancies using Western blot 
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analysis [[12]]. The current study further showed the AhR protein expression in mPE and 
early pregnant placentas. Interestingly, the higher AhR protein levels were associated with 
mPE, while our previous work detected similar levels of AhR protein in normal term and 
sPE placentas [[12]]. Although mechanisms underlying such differential AhR protein 
expression between mPE and sPE placentas remain to be elucidated, it is possible that such 
differences might attribute to the shorter gestation ages in sPE than mPE pregnancies since 
women with sPE were much more likely to suffer premature delivery. This is also in line 
with our present observation that placental AhR protein levels were much lower in early 
pregnancy than those in term pregnancy. These data also support the notion that the 
pathogenesis of mPE and sPE may not be completely the same as proposed previously 
[[15]]. Moreover, the higher protein levels of AhR could be potentially used as a marker for 
predicting mPE when in conjunction with other clinical diagnoses. 
Our current observations that AhR protein was mainly present in the cytoplasm and nuclei 
of syncytiotrophoblasts, but not in cytotrophoblast cells in both first trimester and full term 
placentas were in agreement with recent findings by Stejskalova et al [[16]], suggesting that 
AhR might predominantly act on syncytiotrophoblasts during human pregnancy. The exact 
roles of AhR in syncytiotrophoblasts are currently unclear. However, given that 
syncytiotrophoblasts are terminally differentiated cells and are also responsible for 
producing many types of steroid and peptide hormones. It is possible that AhR might 
dynamically mediate syncytiotrophoblast differentiation and placental hormonal synthesis, 
particularly during late pregnancy, to support pregnancy and embryo/fetal development in 
uteri as AhR null female mice have difficulties to do so [[6],[7]]. In addition, higher AhR 
protein levels in term placentas than early pregnant placentas also suggest that the former 
might be more sensitive to AhR ligands’ stimulation regardless if these ligands are derived 
from exogenous or endogenous sources [[17],[18]]. 
In conclusion, together with the recent findings of endogenous AhR ligands produced by 
human and animals [[17],[18]], the current data strongly support the notion that AhR plays 
important physiological roles in mediating normal differentiation and development of 
cytotrophoblast as well as placental endothelial cells to maintain successful pregnancy. 
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